| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2403aad8bbbf284fed86d63332054c16 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5042 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ba1d2f22e23abc00505f3ff0c55527f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a02b4ae2c82407a9856bc294b7d66033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abd8b3ee9e66a46bb964090c4f9e2b83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ad76c469087454221cc1d96d6e53f24 |
| publicationDate |
2016-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20160055122-A |
| titleOfInvention |
Use of high dose pridopidine for treating huntington's disease |
| abstract |
The present invention provides a method of treating a patient suffering from Huntington ' s Disease < RTI ID = 0.0 > disease < / RTI > comprising periodically administering to a patient a pharmaceutical composition comprising predopidine or a pharmaceutically acceptable salt thereof, Provide a treatment method. The invention further provides a method of treating a human patient suffering from Huntington ' s Disease comprising periodically orally administering to a patient a pharmaceutical composition comprising predopidine hydrochloride such that greater than 90 mg of predopidine per day is administered to the patient . |
| priorityDate |
2013-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |